ALIM
Price:
$5.56
Market Cap:
$302.38M
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2019-11-04
Stock Exchange
NASDAQ
Ticker
ALIM
According to Alimera Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 363.67M. This represents a change of 35.35% compared to the average of 268.69M of the last 4 quarters.
The mean historical Enterprise Value of Alimera Sciences, Inc. over the last ten years is 93.10M. The current 363.67M Enterprise Value has changed 38.96% with respect to the historical average. Over the past ten years (40 quarters), ALIM's Enterprise Value was at its highest in in the June 2024 quarter at 361.49M. The Enterprise Value was at its lowest in in the March 2023 quarter at 46.10M.
Average
93.10M
Median
70.69M
Minimum
55.00M
Maximum
181.20M
Discovering the peaks and valleys of Alimera Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 185.67%
Maximum Annual Enterprise Value = 181.20M
Minimum Annual Increase = -45.37%
Minimum Annual Enterprise Value = 55.00M
Year | Enterprise Value | Change |
---|---|---|
2023 | 165.74M | 185.67% |
2022 | 58.02M | -4.72% |
2021 | 60.89M | 10.71% |
2020 | 55.00M | -16.34% |
2019 | 65.74M | -13.09% |
2018 | 75.64M | -24.40% |
2017 | 100.06M | 67.89% |
2016 | 59.60M | -45.37% |
2015 | 109.10M | -39.79% |
2014 | 181.20M | 28.82% |
The current Enterprise Value of Alimera Sciences, Inc. (ALIM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
94.88M
5-year avg
81.08M
10-year avg
93.10M
Alimera Sciences, Inc.’s Enterprise Value is greater than Shuttle Pharmaceuticals Holdings, Inc. (3.88M), greater than Lifecore Biomedical, Inc. (269.28M), less than Mallinckrodt plc (2.62B), greater than Journey Medical Corporation (95.90M), greater than Lucy Scientific Discovery Inc. (2.06M), greater than Adamis Pharmaceuticals Corporation (-6593458674.00), greater than Organogenesis Holdings Inc. (347.97M), greater than Cyclo Therapeutics, Inc. (21.39M), greater than Athenex, Inc. (9.07M), less than MedMen Enterprises Inc. (371.70M), greater than China Pharma Holdings, Inc. (6.36M), greater than Halo Collective Inc. (15.22M), greater than China SXT Pharmaceuticals, Inc. (-7431090.00), greater than Petros Pharmaceuticals, Inc. (3.44M),
Company | Enterprise Value | Market cap |
---|---|---|
3.88M | $3.42M | |
269.28M | $147.38M | |
2.62B | $4.52M | |
95.90M | $97.00M | |
2.06M | $906.91K | |
-6593458674.00 | $7.25M | |
347.97M | $327.46M | |
21.39M | $19.51M | |
9.07M | $2.33M | |
371.70M | $138.32K | |
6.36M | $3.04M | |
15.22M | $895.00 | |
-7431090.00 | $1.99M | |
3.44M | $3.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alimera Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Alimera Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Alimera Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Alimera Sciences, Inc. (ALIM)?
What is the 3-year average Enterprise Value for Alimera Sciences, Inc. (ALIM)?
What is the 5-year average Enterprise Value for Alimera Sciences, Inc. (ALIM)?
How does the current Enterprise Value for Alimera Sciences, Inc. (ALIM) compare to its historical average?